Switching From Twice-Daily Raltegravir Plus Tenofovir...

HIV Clinical Trials 2014 / 04 Vol. 15; Iss. 2

Switching From Twice-Daily Raltegravir Plus Tenofovir Disoproxil Fumarate/Emtricitabine to Once-Daily Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Disoproxil Fumarate in Virologically Suppressed, HIV-1–Infected Subjects: 48 Weeks Data

Mills, A., Crofoot, G., Ortiz, R., Rashbaum, B., Towner, W., Ward, D., Brinson, C., Kulkarni, R., Garner, W., Ebrahimi, R., Cao, H., Cheng, A., Szwarcberg, J.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
15
Language:
english
Journal:
HIV Clinical Trials
DOI:
10.1310/hct1502-51
Date:
April, 2014
File:
PDF, 568 KB
english, 2014
Conversion to is in progress
Conversion to is failed